# Circulating Tumor DNA Genotyping for Biological Monitoring of Patients Treated in the FIL-Rouge Clinical Trial

> **NCT05066555** · — · COMPLETED · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 100 (actual)

## Conditions studied

- Hodgkin Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05066555
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-08
- **Primary completion:** 2021-11-02
- **Final completion:** 2024-11-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05066555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05066555, "Circulating Tumor DNA Genotyping for Biological Monitoring of Patients Treated in the FIL-Rouge Clinical Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05066555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*